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Abstract 
Viral infections of the central nervous system (CNS) are underdiagnosed and their etiology 
often unknown.  
Patients with a diagnosis of viral CNS infection were studied, including risk factors, 
epidemiological, clinical, laboratory and radiological criteria. We aimed to evaluate if 
timing of lumbar puncture and different cerebrospinal fluid characteristics were associated 
with a higher index of etiological diagnosis. A check list of serologic and molecular 
virology tests to be performed on blood and cerebrospinal fluid was developed.  
The study was conducted during the 2009-2015 period. 
Overall, 68 cases have been diagnosed. Males were 40/68 (55.7%), mean age was 49.6 
(range 18-85). Etiology was established in 34/68 (50.0%) as follows: VZV 9 cases, Toscana 
Virus 7, HSV-1 6, Enterovirus 5, HSV-2 3, West Nile 2, HHV-7 and parvovirus B19 one.  
When lumbar puncture was performed within 72h from the onset of symptoms, an etiologic 
diagnosis was made in 17/30 cases (56.6%); when lumbar puncture was performed after 72h 
from the onset of symptoms, an etiologic diagnosis was made in 11/32 cases (34.3%).  
At CSF examination, leukocytes count was increased (>5x109/L) in 65/67 (97.0%) and 
lymphocytes were prevalent in 63/67 (94.0%); glucose was reduced (<50 mg/dl) in 12/67 
(17.9%), but CSF/blood glucose ratio was less than 40% only in 2/67 (2.9%); proteins were 
increased (>60 mg/dl) in 45/67 (67.1%). Overall mean CSF leukocytes count was 
285x109/L while mean leukocytes count of Enterovirus infections was 152x109/L and that 
of VZV infections was 625x109/L. Mean protein concentration was 106.2 mg/dl while that 
of VZV infections was 237.9 mg/dl. 
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Additionally, a seroprevalence survey for Toscana Virus was conducted on consecutive 
patients admitted in the Infectious Diseases Unit, regardless the symptoms: IgG or IgM 
were positive in 35/100 cases (35%), with a clear trend to increase with age. 
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Introduction 
 
An overwhelming number of people are affected by different viral infections every day.  
Clinically relevant involvement of the central nervous system (CNS) by viruses is a 
relatively uncommon event in the setting of these viral infections, but still represents a 
significant cause of morbidity and mortality, especially among infants and 
immunocompromised hosts, and a phenomenon greatly underestimated and unknown. 
Possible causes of meningitis include bacteria, viruses, fungi, parasites, autoimmune 
diseases and medications. Viral infections of the CNS are probably the leading cause of 
meningitis but differentiating between viral and bacterial meningitis, presents still a 
considerable challenge, which aims to reduce antimicrobial resistance and hospital costs.  
Viral infections of the CNS include different clinical features, most commonly encephalitis, 
meningitis and myelitis. However these are often concomitant and thus cannot be easily 
distinguished based on clinical findings alone. 
Other less established and more unusual clinical features include progressive neurologic 
disorders, such as post-infectious encephalomyelitis in the setting of measles or Nipah virus 
encephalitis, and postpoliomyelitis syndrome occurring years after acute poliovirus 
infection. 
The spectrum of possible involvement depends on the specific viral agent, host immune 
status, genetic asset and environmental factors. Examples of these factors include viral 
agents such as VZV which involve very often the brain parenchyma rather than the 
meninges alone, associated morbidity and mortality in immunocompromised patients or 
viral epidemics in specific periods of the year. 
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Furthermore, vector-transmitted viral infections causing a wide range of manifestations, 
including CNS involvement, in recent years have been responsible of epidemics in areas 
where they had never been present or had disappeared since decades (emerging and re-
emerging infections). 
 
 
 
 
 
Etiology and epidemiology 
 
In the United States, more than 10,000 cases of viral meningitis are reported annually, but 
the actual incidence may be as high as 75,000. Lack of reporting is due to the uneventful 
clinical outcome of most cases and the inability of some viral agents to grow in culture. 
According to reports from the Centers for Disease Control and Prevention (CDC), inpatient 
hospitalizations resulting from viral meningitis range from 25,000-50,000 each year. An 
incidence of 11 new cases per 100,000  people  per year has been estimated in some reports. 
[1] 
The CDC estimates an annual incidence of approximately 20,000 new cases of encephalitis 
in the United States. The annual incidence of viral encephalitis is most likely 
underestimated, especially in developing countries, because of problems with pathogen 
detection.   
As a consequence of mumps, measles, and rubella vaccination, enteroviruses have 
supplanted mumps as the most common cause of viral meningitis in children.[2,3] 
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Enteroviruses are said to account for 80% of cases in adults, but a wider range of causes is 
increasingly implicated.[4,5] 
Worldwide, rabies and Japanese encephalitis virus (JEV) are responsible for an estimated 
annual mortality of 60,000 and 17,000 people, respectively. Cases of JEV encephalitis are 
restricted to Asia, whereas rabies is a scourge throughout Southeast Asia, Africa and Latin 
America and occurs, although less frequently, in other areas worldwide. [6] 
 
 
 
 
Enteroviruses 
Enteroviruses account for the majority of cases of viral meningitis in many case histories. 
Human enteroviruses cause a wide variety of diseases including polio, hand, foot and mouth 
disease, myocarditis, and aseptic meningitis, most commonly affecting and transmitted 
through children. [7–10] 
They are members of the Picornaviridae family ("pico" for small, "rna" for ribonucleic 
acid). 
Based on their antigenic properties, the original 64 HEV serotypes were initially grouped 
into polioviruses (PV), coxsackieviruses A (CA), coxsackieviruses B (CB), echoviruses (E), 
and the more recently identified enteroviruses (EV) 68 to 71. A new HEV classification 
based on molecular and biological data has recently been proposed as an alternative to the 
antigenic classification. This classification groups enteroviruses into five species: (1) PV, 
including poliovirus types 1, 2 and 3; (2) HEV-A, including 11 coxsackieviruses A and 
EV71; (3) HEV-B, including all coxsackieviruses B, all echoviruses, EV69 and CA9; (4) 
                                                                                                                            
10         
 
HEV-C, including 11 other coxsackieviruses A; and (5) HEV-D, including EV68 and EV70. 
The enteroviruses previously classified as E22 and E23, which were shown to group 
independently, now constitute a new genus, Parechovirus (with two serotypes), in the 
family Picornaviridae. [11] 
Coxsackie and echovirus are the most common causes of viral meningitis. However, other 
viruses such as poliovirus and enterovirus 71 (EV71) have also been demonstrated to have 
the ability to evoke aseptic meningitis. [12] Coxsackievirus B subgroups alone account for 
more than 60% of meningitis cases in children younger than age 3 months.  
Enteroviruses are ubiquitous in the summer and early fall; their propensity to cause 
infection during the warmer months is the major factor in the higher incidence of aseptic 
meningitis during that time.  
They enter the human host usually via the oral-fecal route, but can also spread through the 
respiratory route. The incubation period of non-polio infections is between 3–7 days and 
that of polio 1-3 weeks and the associated clinical findings may include pharyngitis, 
pleurodynia, rash, and pericarditis. 
Expectant mothers infected with coxsackievirus B may have few symptoms, but their 
infants can acquire the infection perinatally and develop a potentially fatal illness, with the 
infection targeting mainly the heart.  
Enteroviruses 70 and 71, which exhibit strong neurotropism, are associated with 
meningoencephalitis, polio-like paralytic syndromes, and Guillain-Barre syndrome, as well 
as aseptic meningitis. 
The typical presentation of enteroviral meningitis includes headache, nausea, vomiting and 
photophobia. 
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Arboviruses 
Arboviruses account for about 5% of cases of meningitis in North America. 
Arboviruses consist of more than 500 viruses from different viral families, all given the 
common name "ar-bo" for arthropod-borne virus (table 1). 
 
 
Blood-sucking arthropods, usually mosquitoes, serve as vectors for transmission. Some 
arboviruses are transmitted by ticks or other insect vectors such as sandflies. Because 
exposure to mosquitoes or ticks is the risk factor for transmission, the number of infections 
is highest in summer and early fall, consistently with high mosquito populations (Box 1) . 
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Box 1: from ‘Transmission cycles, host range, evolution and emergence of arboviral 
disease’,Scott C. Weaver & Alan D. T. Barrett,Nature Reviews Microbiology 2, 789-801 
(October 2004) 
 
Some of the important arboviruses include the eastern and western equine encephalitis 
viruses, from the Togavirus family; St. Louis encephalitis, West Nile, Japanese B, and 
Murray Valley viruses, from the Flavivirus family; California group and Jamestown Canyon 
viruses, from the Bunyaviridae family. Colorado tick fever is caused by a coltivirus in the 
western regions of the United States. 
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Clinical features of infection include febrile diseases and hemorrhagic fevers. The most 
common clinical manifestation of the CNS is meningoencephalitis rather than pure 
meningitis. 
Seizures are more common with arboviral meningitis than with any other group of viruses. 
Some agents preferentially infect certain age groups, such as St. Louis encephalitis, which 
affects the elderly, and La Crosse/California serogroup virus, which infects young children. 
Children with St. Louis or California group encephalitis viruses may not exhibit any 
neurologic signs or altered mental status.  
St. Louis encephalitis (SLE) virus is the most common cause of arboviral meningitis, and is 
also the most common mosquito-transmitted disease in the United States.  
Japanese B encephalitis virus, the most common pathogen in epidemic viral meningitis 
worldwide, accounts for more than 35,000 infections annually throughout Asia but is 
estimated to cause 200-300 times that number of subclinical infections. 
Of the arboviruses, West Nile virus caused much attention, as it was first recognized in the 
United States only in 1999 and quickly became an epidemic in 2002, with more than 4,000 
reported cases. In 2008, 1,356 cases were reported.[13]  
Infection with the West Nile virus is usually asymptomatic or manifests as mild symptoms 
of nonspecific fever, myalgia, and fatigue. Symptoms are therefore similar to St Louis 
encephalitis. However, 1 in 150 cases develops a severe disease involving the nervous 
system, with encephalitis reported more than meningitis. In 2008, 687 cases of West Nile 
neuroinvasive disease were reported to the US Centers for Disease Control and Prevention 
(CDC) from all across the United States. [14]  
In Europe, there is a history of recognized WNV outbreaks, characterized by human 
neuroinvasive disease, dating back to the mid-1990s. [15] However, since 2008, there has 
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been an unprecedented increased WNV activity, including the sustained emergence of a 
lineage 2 WNV, with a rapid rise in the number of cases of neuroinvasive disease of 
animals and humans. [16,17] In 2012, there was a peak of 937 WNV cases in Europe and 
surrounding countries, with ongoing activity in 2013, with preliminary data reporting 783 
WNV human cases, including 86 in Greece and 302 in Serbia. [18] 
Neuroinvasive West Nile disease occurs more often in elderly persons. 
 
 
 
Toscana Virus 
Toscana virus (TOSV) is an arthropod-borne virus, identified in 1971, from Phlebotomus 
perniciosus and Phlebotomus perfiliewi in central Italy. TOSV belongs to the Phlebovirus 
genus within the Bunyaviridae family. As other bunyaviruses, the genome of TOSV 
consists of 3 segments (S for small, M for Medium, and L for Large) respectively encoding 
non structural and capsid proteins, envelope structural proteins, and the viral RNA-
dependant RNA-polymerase. It is transmitted by sand flies. Therefore its distribution is 
bound to that of the arthropod vectors, and virus circulation peaks during summertime when 
sand fly populations are active. The first evidence of its pathogenicity in humans, 
specifically its propensity to cause central nervous system (CNS) infections such as 
meningitis and encephalitis, was reported in central Italy. Only after 2000, it was recognized 
that TOSV had a much larger geographic distribution than previously believed, and was 
present in most of the Western European countries located on the northern border of the 
Mediterranean Sea (Portugal, Spain, France, Greece, Croatia) as well as eastern countries 
such as Cyprus and Turkey. In the countries where TOSV is present, it is among the three 
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most prevalent viruses causing meningitis during the warm season, along with enteroviruses 
and herpesviruses. Up to now, epidemiological data concerning Northern Africa and other 
countries located south of the Mediterranean are scarce. TOSV must be considered as an 
emerging pathogen. Despite the important role played by TOSV in CNS infections, it 
remains a neglected agent and is rarely considered by physicians in diagnostic algorithms of 
CNS infections and febrile illness during the warm season, probably because of the lack of 
information. [19] 
 
 
 
Adapted from Depaquit J et al, Eurosurveillance, Volume 15, Issue 10, 11 March 2010 
 
 
 
Mumps 
A member of the Paramyxoviridae family, mumps virus was one of the first known 
causative agents of meningitis and meningoencephalitis.[20]  
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The incidence of mumps in the vaccination era has decreased significantly to 1 per 100,000 
population in the United States. 
Nonetheless, outbreaks have occurred in vaccinated populations, including a large epidemic 
in the United Kingdom that peaked in 2005 and several outbreaks in the American Midwest 
in 2006.[21] In addition, mumps continues to cause 10-20% of meningitis and 
meningoencephalitis cases in parts of the world where vaccines are not readily accessible.  
Males 16-21 years of age are at highest risk for developing this infection, with a 3:1 
male/female ratio. 
Clusters of cases occur in schools and colleges in the winter months. 
Concomitant parotitis is a helpful clinical tool, but it may be absent in as many as half of 
cases with CNS involvement. 
A cohort study of 12,000 unvaccinated children from northern Finland revealed that mumps 
meningoencephalitis accounted for 40.9% of all viral CNS infections. Mumps also remains 
an important cause of aseptic meningitis in England and Japan.  
In 2003, epidemics of aseptic meningitis following measles, mumps, rubella (MMR) 
vaccination campaigns in various nations (including Brazil and the UK) prompted the 
Global Advisory Committee on Vaccine Safety to conduct a review of vaccine-derived 
mumps meningitis.[22] At the time, the committee stated that certain strains of the mumps 
vaccine (Urabe, Leningrad-Zagreb, and Leningrad-3 strains) were associated with higher 
incidences of post-vaccination aseptic meningitis. In 2006, the committee determined that 
the international literature reviewed was actually inconclusive and that further studies were 
needed.[23] Even so, replacement mumps components were developed and vaccines were 
reformulated worldwide.  
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Herpes family viruses 
Herpes simplex virus HSV-1, HSV-2, varicella-zoster virus (VZV), Ebstein-Barr virus 
(EBV), cytomegalovirus (CMV), and human herpesvirus-6 (HHV-6) collectively cause 
approximately 4% of cases of viral meningitis, with HSV-2 being the most common 
offender. The viruses may attack at any time of the year.  
Meningitis caused by these viruses is often self-limited. When associated with encephalitis, 
however, the mortality rate can be high. Early treatment with acyclovir can significantly 
reduce morbidity.  
HSV-1 remains the most common cause of sporadic encephalitis, while HSV-2 infections of 
CNS are mostly restricted to aseptic meningitis.  
HSV-2 genital infection may precede meningitis; sexual contact with actively infected 
individuals is one of the known risk factors.  
In one review, however, only 3 of 23 patients with HSV-2 meningitis had a history of prior 
genital herpes or had genital lesions noted at the time of presentation.[24] Maternal-fetal 
transmission of HSV-2 can occur, leading to significant systemic sequelae, including 
infantile septicemia and death.  
EBV, HSV-1, and especially HSV-2 have been associated with Mollaret meningitis, a rare, 
benign, recurrent type of meningitis that resolves spontaneously. Mollaret cells (activated 
monocytes with an atypical appearance of enlarged, bilobed nuclei and amorphous 
cytoplasm) are found in the CSF usually on the first day of symptoms. HHV-6, EBV, and 
the human immunodeficiency virus (HIV) have also been implicated. These viruses are all 
known to remain latent within the nervous system. 
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CMV infections occur mostly in immunocompromised hosts. CMV may cause subacute 
encephalitis in patients with AIDS. Congenital CMV, which is a much more serious form of 
infection, has significant associated morbidity and mortality.  
Childhood or adult chickenpox infections by VZV rarely are complicated by meningitis. 
Adult zoster involving any dermatome may lead to meningitis or meningoencephalitis. 
 
 
Lymphocytic choriomeningitis virus 
LCMV belongs to arenavirus family which is characterized by a single-stranded RNA 
genome. Now a rare cause of meningitis, the virus is transmitted to humans by contact with 
rodents (eg, hamster, rats, mice) or their excreta, especially urine. Human cases of LCM are 
most common in autumn. Persons at highest risk of infection are laboratory workers, pet 
owners, or persons under unhygienic living conditions.  
 
 
Adenovirus 
Adenovirus infections are ubiquitous but these result mostly in subclinical disease. 
Adenovirus infection is a rare cause of meningitis in immunocompetent individuals but a 
major one in patients with acquired immunodeficiency syndrome (AIDS). The infection 
may occur simultaneously with an upper respiratory infection.  
 
Measles 
This Morbillivirus is another causative agent of meningitis which has become rare. Only 1 
in 1000 to 2000 patients with measles develops clinical signs of encephalitis. The typical 
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maculopapular rash on patients with measles is very useful in the clinical diagnosis. Most 
cases occur in younger people in schools and colleges. Still a worldwide health threat, 
measles has the highest attack rate of any infection. Eradication of measles is an important 
goal of the World Health Organization (WHO). 
 
 
HIV 
Meningitis is multifactorial in patients with HIV or AIDS. Aseptic meningitis may be 
caused by HIV itself and in this case it has atypical features such as chronicity and 
recurrence. About the time of seroconversion, patients may present with CSF pleocytosis, 
elevated protein level and, occasionally, high intracranial pressure.  
Reports have suggested that as many as 5-10% of HIV infections can be heralded by 
meningitis. Aside from the usual meningeal signs, HIV infections may also cause global 
encephalopathy, seizures, and focal neurologic deficits. Some patients develop chronically 
abnormal CSF findings with mild or no symptoms. HIV often can be isolated from the CSF.  
 
Others 
Other causative agents of meningitis include Rabies virus which usually causes encephalitis 
but in some cases may cause meningitis too, Rotavirus, Influenza and Parainfluenza virus. 
However these are very rare and often fatal. 
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Pathophysiology and clinical manifestations 
 
CNS invasion may occur via several mechanisms but most viral pathogens gain access via 
either of two main routes: hematogenous and neural. Most neurotropic viruses first multiply 
at extraneural sites (initially at the portal of entry), establish viremia, and then cross the 
blood-brain barrier (BBB) to invade the CNS. [25, 26] Neural penetration refers to spread 
along nerve roots and is usually limited to herpes viruses (HSV-1, HSV-2, VZV) and 
possibly some enteroviruses.  
Multiple host barriers prevent viral inoculum from causing clinically significant infection. 
These include local and systemic immune responses, skin and mucosal barriers, and the 
blood-brain barrier (BBB).  
The virus replicates in the portal of entry (ie, respiratory or gastrointestinal mucosa) and 
gains access to the bloodstream. Primary viremia introduces the virus to the 
reticuloendothelial organs (liver, spleen, lymph nodes). If the replication persists despite 
immunologic defenses, secondary viremia occurs, which is thought to be responsible for 
seeding of the CNS. Rapid viral replication likely plays a major role in overcoming host 
defenses.  
The actual mechanism of viral penetration into the CNS is not fully understood. The virus 
may cross the BBB directly at the capillary endothelial level or through natural defects, 
such as the area postrema and other sites that lack a BBB.  
The inflammatory response is seen in the form of pleocytosis; polymorphonuclear 
leukocytes (PMNs) lead the differential cell count in the first 24-48 hours, followed later by 
increasing numbers of monocytes and lymphocytes. The CSF lymphocytes have been 
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recognized as T cells, although B cell immunity is also important in defending against some 
viruses.  
Evidence exists that some viruses gain access to the CNS by retrograde transport along 
nerve roots. For example, the likely pathway for HSV-1 encephalitis is via the olfactory or 
trigeminal nerve roots, with the virus being transported by the olfactory fibers to the basal 
frontal and anterior temporal lobes.  
Upon presentation, most patients report fever, headache, irritability, nausea, vomiting, 
nuchal rigidity, rash, or fatigue within the previous 18-36 hours. Constitutional symptoms 
of vomiting, diarrhea, cough, and myalgias appear in more than 50% of patients.  
For several weeks or longer, children may experience irritability, incoordination, and an 
inability to concentrate. 
Headache is almost always present in patients with viral meningitis and is often reported as 
severe. However, the classic description of abrupt onset of the "worst headache of my life," 
attributable to aneurysmal subarachnoid hemorrhage, is uncommon.  
History of temperature elevation occurs in 76-100% of patients who come to medical 
attention. A common pattern is low-grade fever in the prodromal stage and higher 
temperature elevations at the onset of neurological signs.  
Younger children may not report headache and may simply be irritable. 
Newborns may present with poor feeding and lethargy. 
Some viruses cause rapid onset of the above symptoms, while others manifest as 
nonspecific viral prodromes, such as malaise, myalgia, and upper respiratory symptoms. In 
many cases, symptoms have a biphasic pattern; the nonspecific flu-like symptoms and low-
grade fever precede neurologic symptoms by approximately 48 hours. With the onset of 
neck stiffness and headache, the fever usually returns.  
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Meticulous history taking is essential and must include evaluation of exposure to ill 
contacts, mosquitoes, ticks, outdoor activity in areas of endemic Lyme disease, travel 
history with possible exposure to tuberculosis, as well as history of medication use, 
intravenous drug use, and sexually transmitted disease risk.  
Some general physical findings in viral meningitis are common to all causative agents.  
The classically taught triad of meningitis consists of fever, nuchal rigidity, and altered 
mental status, but not all patients have all 3 symptoms.  
Fever is very common (80-100% of cases) and usually ranges from 38°-40°C. 
Neck stiffness or other signs of meningeal irritation (Brudzinski or Kernig sign) may be 
seen in more than half of patients, but these symptoms are generally less severe than they 
are in bacterial meningitis. Pediatric patients, especially neonates, tend not to exhibit nuchal 
rigidity on examination.  
Irritability, disorientation, and altered mentation may be seen. 
Severe lethargy or bulging fontanelle in neonates is a sign of increased intracranial pressure 
but may be absent in more than half of all cases. The neonate may exhibit hypotonia, 
irritability, and poor feeding. The clinical picture can mimic neonatal bacterial septicemia 
accompanied by multiple organ system involvement.  
Headache is common and is characteristically severe. 
Photophobia is relatively common but may be mild. Phonophobia may also be present. 
Seizures can occasionally occur and are usually the result of the fever, although the 
involvement of brain parenchyma (encephalitis) should be considered.  
Global encephalopathy and focal neurologic deficits are rare but can be present. Deep 
tendon reflexes are usually normal but may be hyperactive.  
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Various signs of specific viral infection can aid in diagnosis. These include the following: 
 Pharyngitis and pleurodynia in enteroviral infections 
 Skin manifestations, such as zoster eruption from VZV, maculopapular rash from 
measles and enteroviruses, vesicular eruption from herpes simplex, and herpangina 
from coxsackievirus A infections  
 Pharyngitis, lymphadenopathy, and splenomegaly, which suggest EBV infection 
 Immunodeficiency and pneumonia, which should suggest adenovirus, CMV, or HIV 
as the causative agent 
 Parotitis and orchitis, from mumps 
 Gastroenteritis and rash, which occur with most enteroviral infections 
The prognosis for viral meningitis is usually excellent, with most cases resolving in 7-10 
days. Implicit in the diagnosis is the self-limited nature of this disease. The exception falls 
with the neonatal patients, in whom viral meningitis can be fatal or associated with 
significant morbidity.  
Concomitant encephalitis adds significant potential for adverse outcomes. Concurrent 
systemic manifestations, such as pericarditis and hepatitis, are other indicators of poor 
prognosis. 
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Diagnosis 
 
General assessment 
 
Routine chemistry and hematology tests, arterial blood gas analysis, coagulation studies, 
and liver function tests should be performed.  
The serum white blood cell (WBC) count is not a sensitive indicator of the severity of 
infection, especially in the immunocompromised, neonatal, or elderly patient. However, a 
high WBC, particularly neutrophils, suggests a bacterial etiology. 
The serum sodium level may be abnormal because of dehydration or the rare occurrence of 
syndrome of inappropriate antidiuretic hormone secretion (SIADH). Since abnormal sodium 
levels may contribute to neurological symptoms, these must be followed up and corrected if 
needed. 
The serum amylase level may be elevated in cases of viral meningitis that are caused by 
mumps, even in the absence of parotitis. 
Reports have shown high C-reactive protein (CRP) levels in the serum of children with 
bacterial meningitis whose CSF Gram stain findings were negative for bacteria. However, a 
comparable group of children with viral meningitis did not have similar elevations in serum 
CRP (i.e., 50-150 in bacterial meningitis group vs < 20 in the viral meningitis group).  
Microscopy of CSF should be performed to better define the nature of white cells and detect 
bacteria and fungi. 
All patients whose condition is not improving clinically within 24-48 hours should have a 
more extensive workup to discern the cause of meningitis.  
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Cerebrospinal fluid examination 
 
CSF examination is the most important test in establishing the cause of meningitis. Prior to 
lumbar puncture (LP), a computed tomography (CT) scan should be performed in patients 
with any abnormal neurologic sign, to rule out an intracranial lesion or obstructive 
hydrocephalus. 
A high WBC count in the CSF (especially neutrophils), a high protein level, and a low 
glucose level should suggest a diagnosis of bacterial meningitis, although some viral 
pathogens may produce similar CSF profiles. In fact, pleocytosis with WBC counts in the 
range of 50 to more than 1,000 x 109/L of blood has been reported in viral meningitis. 
Mononuclear cell predominance is the rule, but PMNs may make up most cells in the first 
12-24 hours; the cell count is usually then dominated by lymphocytes in the classic CSF 
pattern of viral meningitis. This helps to distinguish viral from bacterial meningitis, which 
has a much higher cell count and a predominance of PMNs in the cell differential, although 
this is not an absolute rule. In fact, a retrospective multicenter study found that neither the 
presence nor quantity of immature neutrophils (bands) in CSF independently predicted 
bacterial meningitis among children with CSF pleocytosis.[27]  
The CSF protein level usually is only slightly elevated, but it can range from normal to as 
high as 200 mg/dL. 
The glucose level is normal in most cases, but severe hypoglycorrhachia has been reported, 
especially with LCMV or the mumps virus. Very low glucose levels with a lymphocytic 
pleocytosis may be seen in tuberculous meningitis.  
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Etiologic diagnosis 
 
Blood, feces, and throat swabs need be sent for viral serology and cultures. 
Serum titers of antibodies against possible etiologic infective agents should be obtained at 
admission. Additional serum collection 10-21 days later may aid in discerning rising titers 
in the antibodies against specific viral pathogens; a 4-fold increase in viral antibodies 
confirms the diagnosis. This is particularly useful for arboviral and LCMV cases, but it also 
is helpful in ruling out toxoplasmosis, leptospirosis, borreliosis, and rickettsial infections. 
Although some of these studies do not yield an immediate result for clinical decision 
making, they may be useful for prognostication.  
Real-time PCR testing for enterovirus was first cleared for marketing in 2007 by the US 
Food and Drug Administration (FDA) and is now available through commercial 
laboratories.[28] Results are available in approximately 3 hours, as opposed to days to 
weeks in traditional PCR studies. In clearing the test, the FDA cited a multicenter study in 
which 96% of patients who tested positive did have viral meningitis, and 97% of patients 
who tested negative did not have viral meningitis.  In a retrospective study of routine PCR 
testing of CSF for enterovirus—using a test with turnaround time of 23 hours—
confirmation of enteroviral meningitis by PCR decreased the length of hospitalization and 
the duration of antibiotic use among infants aged 90 days or younger.[29] Among 22 
children with meningitis due Enterovirus, in 10 patients, genome was detected in CSF only; 
in 3 patients in serum only, and in 9 patients in both. Therefore, the test on CSF seems to be 
much more sensitive, but the test on serum might detect an additional small group of cases. 
[30] 
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In recent years, PCR on CSF has become the gold standard for the diagnosis of viral 
infections of the CNS. Rapid viral clearance was typical for HSV, VZV, CMV, and EV 
infections, although the maximum duration of viral detection was 15days for HSV and 
12days for VZV, respectively. This suggests that the detection of HSV, VZV, CMV, and 
EV strongly indicates symptomatic viral CNS disease. [31] 
If the results of PCR testing of the CSF and the viral culture for herpes simplex are 
negative, acyclovir can be discontinued; otherwise, a 10-day course is recommended. 
 
 
Imaging 
 
Viral meningitis is usually not associated with imaging abnormalities, thus imaging tests are 
not helpful in establishing a diagnosis or etiology. CT scanning is performed to exclude 
contraindications for lumbar puncture, such as increased intracranial pressure, but whether 
it should be performed in all patients or in selected cases remains controversial. 
 In patients in whom encephalitis is suspected, MRI with contrast enhancement and 
adequate visualization of the frontal and temporal areas, typically affected by HSV, is 
necessary. 
Electroencephalography (EEG) may be performed if encephalitis or subclinical seizures are 
suspected in the altered patient. Periodic lateralized epileptiform discharges (PLEDs) are 
often seen in herpetic encephalitis.  
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Differential Diagnosis 
 
Since viral meningitis presents as aseptic meningitis upon CSF examination a differential 
diagnosis with other etiological factors should be taken into consideration. Such factors 
include infectious agents like Treponema pallidum, Borrelia burgdorferi and 
Mycobacterium tuberculosis, autoimmune diseases, medications or even partial antibiotic 
treatment for bacterial meningitis.  However these account for only a small   proportion of 
cases so careful history taking and laboratory findings should help to rule them out. 
 
 
 
 
Treatment 
 
Treatment for viral meningitis is mostly supportive. Rest, hydration, antipyretics, and pain 
or anti-inflammatory medications may be given as needed. The most important decision is 
whether to initiate antimicrobial therapy empirically for bacterial meningitis while waiting 
for the cause to be identified. Intravenous (IV) antibiotics should be administered promptly 
if bacterial meningitis is suspected.  
No surgical therapy is usually indicated in patients with viral meningitis. In rare patients in 
whom viral meningitis is complicated by hydrocephalus, a CSF diversion procedure, such 
as ventriculoperitoneal (VP) or LP shunting, may be required. Ventriculostomy with an 
external collection system is indicated in the rare cases of acute hydrocephalus.  
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Patients with signs and symptoms of meningoencephalitis should receive acyclovir early to 
possibly curtail HSV encephalitis. Therapy can be modified as the results of Gram stain, 
cultures, and PCR testing become available. Patients in unstable condition need critical care 
unit admission for airway protection, neurologic checks, and the prevention of secondary 
complications.  
Enteroviruses and HSV are both capable of causing viral septic shock in newborns and 
infants. In these young patients, broad-spectrum antibacterial coverage and acyclovir should 
be instituted as soon as the diagnosis is suspected. Special attention should be paid to fluid 
and electrolyte balance (especially sodium), since SIADH has been reported. Fluid 
restriction, diuretics, and, rarely, hypertonic saline infusion may be used to correct the 
hyponatremia. Prevention of secondary infections of urinary tract and pulmonary systems is 
of paramount importance.  
Waiting for LP results should not delay administration of antibiotics when warranted on 
clinical grounds. Broad-spectrum coverage is attained with ampicillin and a third-generation 
cephalosporin (ceftriaxone or cefotaxime; ceftazidime can also be used). Aminoglycosides 
are used in severe infections in neonates or children. Antituberculous, antifungal, and 
antiretroviral medications are reserved for clinically suggested or laboratory-confirmed 
cases.  
Seizures should be treated immediately with IV anticonvulsants, such as lorazepam, 
phenytoin, midazolam, or a barbiturate. Unconscious patients with viral encephalitis may be 
in non-convulsive status epilepticus, and EEG is used to reveal and monitor subclinical 
seizures.  
Cerebral edema does occur in cases of severe encephalitis and may require intracranial 
pressure control by infusion of mannitol, IV dexamethasone, or intubation and mild 
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hyperventilation, with arterial PCO2 around 28-30 mm Hg. Placement of an intracranial 
pressure monitor with transduced intraparenchymal pressure is recommended in these cases.  
Multiple antiviral medications are currently being tested in the general population; their 
impact on preventing the sequelae of viral meningitis and encephalitis has not yet been 
established. In herpetic viral infections, acyclovir is significantly beneficial only if given 
very early in the course of the infection. Suspected cases should be treated as soon as 
possible; in cases complicated by seizures, encephalitis is assumed and acyclovir should be 
initiated.  
Ganciclovir is used for severe CMV-related infections such as congenital infection or 
infection in immunocompromised hosts, including hematologic patients and transplant 
recipients.  
Administration of IV Ig to neonates with overwhelming enteroviral meningitis has met with 
occasional success and is reserved for severe cases lacking other therapeutic options.  
 
 
Prognosis 
 
Viral meningitis is typically a benign disease which resolves spontaneously or with 
appropriate treatment in 7-10 days. In small children and immunocompromised patients 
though it can more often bring complications such as seizures, blindness, hearing loss, 
paralysis or hydrochephalus.  
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Objectives 
 
The main aim of this study was to gather epidemiological data related to viral infections of 
the CNS as well as laboratory findings which could suggest the etiological agent 
responsible for the disease. 
Secondarily, we also aimed at characterizing viral strains, particularly those of emerging 
diseases, such as dengue fever virus, West Nile virus and Toscana virus, correlating them 
with epidemiology, clinical and immunological features. 
 
Methods 
Patients referred to Emergency Department and the Infectious Diseases Unit of the Azienda 
Ospedaliera Universitaria Pisana were screened. Patients who had signs of CNS infection 
underwent a lumbar puncture. Time of LP after onset of symptoms was established. 
Patients were classified as having meningitis if they had neck stiffness, other signs of 
meningeal irritation or laboratory evidence of inflammation at CSF examination, 
encephalitis if they had focal signs, impaired consciousness or seizures, 
meningoencephalitis if they had both. 
A check list of serologic and molecular virology and microbiology tests to be performed on 
blood and cerebrospinal fluid of patients with aseptic infection of the CNS was developed 
and distributed to the Infectious Diseases clinicians (Figure 2). 
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Figure 2. Check List for the etiologic diagnosis of aseptic infection of the Central 
Nervous System infections 
TESTS ON SERUM 
Antibodies 
□ Widal-Wright 
□ Listeria monocytogenes 
□ Borrelia burgdorferi 
□ Leptospira spp 
□ Mycoplasma pneumonia 
□ Chlamydia pneumonia 
□ Coxiella burnetii 
□ Bartonella henselae 
□ Rickettsia conori 
□ Rickettsia typhi 
□ lue screening 
□ Toscana virus 
□ HSV 1 and 2, VZV, CMV, EBV, HHV 6, HHV 7 
□ Coxsackie virus, Echovirus, 
□ Adenovirus 
□ HIV 
□ West Nile 
□ Tick Born Encephalitis (TBE) 
□ Lymphocitic Choriomeningitis Virus (LCMV) 
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□ Parotitis 
□ Rubella 
□ Parvovirus B19 
□ HTLV I/II 
□Chikungunya 
□ Quantiferon 
□ Cryptococcus antigen 
 
TESTS ON CSF 
□ Physical-chemical analysis 
□ Culture and methilene blue stain 
Genomes 
□ HSV 1 and 2, VZV, CMV, EBV, HHV 6, HHV 7 
□ Enterovirus 
□ Adenovirus 
□ Human Respiratory Syncytial Virus 
□ HIV 
□ West Nile 
□ Chikungunya 
□ Parvovirus B19 
Antibodies 
□ Borrelia burgdorferi 
□ Toscana virus 
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□ HSV 1 and 2, VZV, CMV, EBV, HHV 6, HHV 7 
□ Coxsackie virus, Echovirus 
□ Adenovirus 
□ HIV 
□ West Nile 
□ TBE 
□ LCMV 
□ Parotitis 
□ Rubella 
□ Parvovirus B19 
□ HTLV I/II 
□ Chikungunya 
□ PCR, culture and ZN stain for mycobacteria 
□ Cryptococcus antigen 
 
OPTIONAL 
□ Influenza genome on pharingeal and nasal swab during epidemic season 
□ Complete syphilis  serology on serum and CSF in case of positive 
screening or HIV positive patient 
□ HSV 1 and 2 or VZV genome on vesicular cutaneous lesions 
□ JC genome in CSF of immunocompromised patients 
□ Toxoplasma serology on serum and genome in CSF of 
immunocompromised patients with focal lesions 
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□ Serology of Dengue and other Arbovirus based on epidemiology 
□ Genome, culture and ZN stain on sample other than CSF 
□ Incomplete antibodies for Brucella 
 
 
 
Samples have been processed at the laboratory of the Division of Virology of the Azienda 
Ospedaliera Universitaria Pisana. Tests were performed following a priority algorithm. 
Comprehensive biochemical and immunological tests, including lymphocyte subpopulation 
analysis, protein electrophoresis and immunoglobulin subclasses determination, were 
performed. 
Neuroimaging procedures were conducted according to clinical indications. 
Epidemiological, laboratory and clinical data were collected using a specifically designed, 
dedicated database.  
Patients were followed up for at least 6 months. 
Samples of blood and cerebrospinal fluid were stored at -80°C. 
Data from the period 2009 to 2015 was analyzed. 
Additionally, a seroprevalence survey for Toscana Virus was conducted on consecutive 
patients admitted in the Infectious Diseases Unit at admission, regardless the symptoms. 
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Results 
Overall, in the period 2009 to 2015, 68 cases have been diagnosed. Males were 40/68 
(58.8%), mean age was 49.6 (range 18-85). Age distribution is reported in figure 3.  
  
Figure 3. Age distribution of patients with viral infection of the Central Nervous 
System, Pisa, 2009-2015 
 
 
 
Etiology was established in 34/68 (50.0%) as follows: VZV 9 cases, Toscana Virus 7, HSV-
1 6, HSV-2 and Enterovirus 5, West Nile 2, HHV 7 and parvovirus B19 one (table 1).  
When lumbar puncture was performed within 72h from the onset of symptoms, an etiologic 
diagnosis was made in 17/30 cases (56.6%); when lumbar puncture was performed beyond 
72h from the onset of symptoms, an etiologic diagnosis was made in 11/32 cases (34.3%).  
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LP Diagnosed 
cases 
Undiagnosed 
cases 
Total  % 
Within 72h  17 13 30 56.6% 
After 72h 11 21 32 34.3% 
Total  28 34 62 45.1% 
 
 
 
 
In case of VZV, PCR on CSF was positive in 6/9 cases; in 6 cases, including those with 
negative PCR on CSF, CNS involvement occurred in association with varicella or zoster 
and PCR from vesicles was positive in all cases. In case of HSV-1, PCR on CSF was 
positive in 5/6 cases; in that with negative result, PCR was positive on serum. In case of 
HSV-2, PCR on CSF was positive in 2/3 cases; in that with negative result, PCR was 
positive on serum. In 7/7 cases of Toscana virus infection, diagnosis was based on detection 
of IgM on serum; IgM on CSF were also detected in 3/7 cases; in one case PCR on CSF 
was also performed and turned negative. In case of Enterovirus, PCR on CSF was positive 
in three cases and neutralizing antibodies at high titer positive in the remaining two cases. In 
case of West Nile virus, diagnosis was based on detection of IgM on serum. In case of 
HHV-7, PCR was positive on CSF. In case of parvovirus B19, PCR was positive on CSF. 
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Table 1. Etiology of viral infections of the Central Nervous System, Pisa, 2009-2015 
Etiology N % 
Varicella Zoster Virus 9/68 13.2 
Toscana Virus 7/68 10.2 
Herpes simplex Virus 1 6/68 8.8 
Enterovirus 5/68 7.3 
Herpes Simplex Virus 2 3/68 4.4 
West Nile Virus 2/68 2.9 
Parvovirus B19 1/68 1.4 
Human Herpes Virus 7 1/68 1.4 
Unknown 35/68 51.4 
 
 
Figure 4: Etiology of viral infections of the Central Nervous System, Pisa 2009-2015  
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Clinical classification was as follows: 37 patients had meningitis, 26 had 
meningoencephalitis, 2 had myelitis, one had encephalitis, one had 
meningoencephalomyelitis and one had meningoradiculoneuritis (table 2). Among patients 
with meningitis, 5 had a Toscana virus infection, 3 had a HSV-2 infection, including one 
case of relapsing HSV-2 meningitis, namely Mollaret syndrome, 4 had Enterovirus, 1 HHV-
7, 1 West Nile virus, 1 parvovirus B19, 23 an infection of unknown etiology. Among 
patients with meningoencephalitis or meningoencephalomyelitis, 8 had VZV infection, 3 
HSV-1, 2 Toscana virus, 1 Enterovirus, 11 an infection of unknown etiology. One patient 
with meningoradiculoneuritis had VZV infection and one patient with myelitis West Nile 
Infection. 
 
Table 2. Clinical classification of viral infections of the Central Nervous System, Pisa, 
2009-2015 
Clinical classification N % 
Meningitis 37/68 54.4 
Meningoencephalitis 26/68 38.2 
Myelitis 2/68 2.9 
Meningoencephalomyelitis 1/68 1.4 
Meningoradiculoneuritis 1/68 1.4 
Encephalitis 1/68 1.4 
 
Mean length of stay was 12.1 days.  
All patients lived in the catchment area of the Hospital, apart one tourist from Belgium. 
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Impaired immunity was detected in 17 cases: diabetes in 5 cases, malignancy, renal failure 
immunosuppressive therapy and HIV in 2 cases, splenectomy, alcoholism, 
hypogammaglobulinemia, idiopathic CD4 lymphocyte reduction in one case (table 3). 
Among the 16 patients with some kind of immunosuppression, 6 cases had VZV infection, 
3 HSV-1 infection, one Toscana virus infection and 6 an infection of unknown etiology. 
 
 
Table 3. Demography and comorbidities of patients with viral infections of the  
Central Nervous System, Pisa, 2009-2015 
 N % 
Males 
Females 
40/68   
20/68 
58.8 
41.2 
Mean age 49.6 (18-85)  
Immunosuppresive condition   
  Diabetes 5/68 7.3 
  Immunosuppressive treatment 2/68 2.9 
  Malignancy 2/68 2.9 
  HIV 2/68 2.9 
  Hypogammaglobulinemia 1/68 1.4 
  Alcohol abuse 1/68 1.4 
  Renal failure 2/68 2.9 
  Asplenism 1/68 1.4 
  Idiopathic CD4 deficit 1/68 1.4 
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Other comorbidities 
  Migraine/recurrent headache 9/68 13.2 
  Chronic Cerebral Ischemia 4/68 5.8 
  Hypertension 10/68 14.7 
  Body weight excess/Obesity 4/68 5.8 
  Rheumatoid arthritis 2/68 2.9 
  Atopic dermatitis 1/68 1.4 
  Psoriasis 1/68 1.4 
 
At least two among fever, headache, impaired consciousness, focal signs and neck stiffness 
were present at admission in all patients but two, one with West Nile myelitis and one with 
VZV meningoencephalitis and zoster. In particular, fever occurred in 60/68 (88.2%), 
headache in 48/68 (70.5%), neck stiffness in 37/68 (54.4%), impaired consciousness in 
25/68 (36.7%), seizures in 9/68 (13.2%), focal signs in 5/68 (7.3%) (table 4). 
 
Table 4. Clinical features of viral infections of the Central Nervous System, Pisa, 2009-
2015 
Clinical manifestation N % 
Fever 60/68 88.2 
Headache 48/68 70.5 
Neck stiffness 37/68 54.4 
Impaired consciousness 25/68 36.7 
Seizures 9/68 13.2 
Focal signs 5/68 7.3 
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Plain CT scan was negative in all cases but one case of HSV-1 encephalitis who showed a 
hypodensity in the temporal lobe and finally died. Magnetic resonance showed findings 
consistent with infection in 12/30 (40.0%); signs of cerebral parenchymal involvement were 
found in 6/27 (22.2%) cases of meningoencephalitis, 5 due to HSV-1 and one due to VZV. 
EEG revealed abnormalities in 39/56 (69.6%) (table 5). Localized abnormalities were found 
in 21/28 (75%) cases of meningoencephalitis or meningoencephalomyelitis. 
 
 
Table 5. Sensitivity of imaging and EEG in the diagnosis of viral infections of the 
Central Nervous System, Pisa, 2009-2015 
Method Abnormalities 
N % 
Plain CT scan 1/68 1.4 
Magnetic Resonance 12/30 40.0 
EEG 39/56 69.6 
 
At admission, C-reactive protein was altered (>0.5 mg/dl) in 42/64 (65.6%); procalcitonin 
was slightly above normality (>0.5 mg/dl) in 2/38 (5.2%) cases: one VZV encephalitis and 
one Toscana virus meningitis. WBC was increased (>11,000x109/L) in 25/68 (36.7%); an 
increase in the neutrophil count (>7,500x109/L) was observed in 24/68 (35.2%), an increase 
in the lymphocyte count (>3,500x109/L) was observed in 1/68 (1.4%). 
In 9/61 (14.7%) patients a reduced absolute count of CD4 lymphocytes (<410x109/L) was 
detected; in 9/61 (14.7%) patients a reduced absolute count of CD8 lymphocytes 
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(<190x109/L); in 9/61 (14.7%) patients a reduced absolute count of NK lymphocytes 
(<90x109/L). 
Only 5/51 (9.8%) patients had a reduced level of IgG (<700 mg/dl), none had a reduced 
level of IgA or IgM. 
C3c was slightly below normal (90 mg/dl) in 2/17 (11.7%) cases; C4 was slightly below 
normal (10 mg/dl) in 2/17 (11.7%) cases as well (table 6). 
 
 
Table 6. Laboratory features of viral infections of the Central Nervous System, Pisa, 
2009-2015 
Parameter N % 
C reactive protein increase 42/64 65.6 
Procalcitonin increase 2/38 5.2 
WBC increase 25/68 36.7 
Neutrophils increase 24/68 35.2 
CD4+ lymphocyte decrease 9/56 14.7 
CD8+ lymphocyte decrease 9/56 14.7 
NK lymphocyte decrease 9/56 14.7 
IgG decrease 5/51 9.8 
C3c decrease 2/16 12.5 
C4 decrease 2/16 12.5 
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At CSF examination, leukocytes count was increased (>5x109/L) in 65/67 (97%) and 
lymphocytes were prevalent in 63/67 (94.0%); glucose was reduced (<50 mg/dl) in 12/67 
(17.9%), but CSF/blood glucose ratio was less than 40% only in 2/67 (2.9%); proteins were 
increased (>60 mg/dl) in 45/67 (67.1%) (table 7). Overall mean CSF leukocytes count was 
285x109/L while mean leukocytes count of Enterovirus infections was 152x109/L and that 
of VZV infections was 625x109/L. Mean protein concentration was 106.2 mg/dl while that 
of VZV infections was 237.9 mg/dl. 
 
 
Table 7. Cerebrospinal fluid features of viral infections of the Central Nervous System, 
Pisa, 2009-2015 
Feature N % 
WBC count increase 65/67 97.0 
Glucose decrease 12/67 17.9 
CSF/Blood glucose ratio decrease 2/67 2.9 
Proteins increase 45/67 67.1 
 
Acyclovir was administered empirically in all cases and discontinued in case HSV genome 
on CSF was negative. Steroids were administered in 4 cases. Outcome was favorable in all 
but 5 cases: two died and three had permanent consequences, namely paraparesis in one 
case and impaired mental status in two cases. 
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As far as the seroprevalence for Toscana virus is concerned, IgG or IgM were positive in 
34/100 cases (34%), with a clear trend to increase with age: 0% from 16 to 20, 22.1% from 
21 to 30, 26.7% from 31 to 40, 31.6% from 41 to 50, 25.3% from 51 to 60, 33.3% from 61 
to 70, 52.6% above 70. Livorno and Massa Carrara areas resulted to have the highest 
prevalence (80 and 75% respectively). 
 
 
Figure 5. Toscana virus seroprevalence by age, AOUP, 2012-13 
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Discussion 
 
Certainly, sample size cannot allow any definitive conclusions. However, in the study 
period an etiologic diagnosis was made in 50.0% of cases, which is consistent with what 
others reported. [32, 33] 
This result is encouraging and prompts us to provide further efforts in this direction. 
Revision of existing algorithms, dissemination meetings, preparation of graphic materials 
such as posters and flow charts, might be considered in the future. 
The fact that an earlier lumbar puncture (<72h) was associated to a higher probability of 
detecting viral genome in CSF (56.6% versus 34.3%) although statistically not significant 
(p=0.0812) should prompt us not to delay such a crucial procedure. A higher number of 
cases may be necessary to achieve a significant value.  
Clinical relevance of viral infections of the CNS justifies an aggressive diagnostic approach. 
It has been reported that the realization of a brain scanner before the lumbar puncture was 
associated with a significant delay in the realization of the lumbar puncture in the 
Emergency Unit. [33] This is consistent also with our case series, because almost all 
patients had undergone plain CT scan before lumbar puncture, also when no strict 
indications existed. However, among patients who underwent lumbar puncture beyond 72 
hours from the onset of symptoms, the delay was mainly due to delay in accessing the 
hospital, that means general practitioners should also be sensitized on the issue. 
Overall, the data of the period 2009 to 2015 gives a picture of the local epidemiology of the 
viral infections of the CNS. 
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Our study does not allow to obtain data on incidence. However, also considering that our 
hospital is a referral center, viral infections of the CNS seem to have a limited impact in our 
communities. Still, we can assume that cases accessing health services are only the most 
severe ones and many more occur with no or mild clinical manifestations. 
Age of patients ranged from 18 to 85 years but almost half of patients had from 30 to 50 
years. Notably, mean age of patients having meningitis was 49.6 while mean age of those 
having involvement of brain parenchyma was 63.6, meaning that older patients more often 
develop severe forms. 
Etiology of our case series generally reflects that reported in the literature for adults, with 
some peculiarities. 
VZV turned out to be the first cause of viral infection of the CNS. Among the 9 patients 
with VZV infection, all but one had signs of encephalitis. Other case series report 
Enterovirus to be largely the first cause of meningitis while HSV-1 and HSV-2 to be the 
first cause of encephalitis, followed by VZV. [34, 31] In 7/9 cases some kind of 
immunosuppression was revealed. One case of encephalitis reported persistent 
neurocognitive impairment and one case of meningoradiculoneuritis reported paraparesis. 
One case occurred during varicella and 5 in association with zoster. This should remind us 
about the importance of suspecting CNS involvement in such cases, especially in case of 
immunosuppressed or otherwise fragile patients, to refer the case to hospital and/or timely 
start antiviral treatment. The live attenuated vaccine for VZV is very effective in preventing 
varicella and therefore complications of acute disease, including those affecting the CNS. In 
fact, although cases of meningitis as adverse events following vaccination have been 
described, incidence is low. [35] However, impact of vaccination on reactivation and its 
most severe manifestations has not been established. For instance, among 84 children aged 
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1 month to 18 years, admitted with neurological complications of acute disease, including 
encephalitis, only 4 had been vaccinated. [36] Instead, out of 7 children with meningitis or 
encephalitis, 4 had received at least one dose of vaccine. [37] Other cases of CNS infection 
due to reactivation of vaccine strain have been reported. [38, 39, 40] A live attenuated anti-
zoster vaccine has been recently proposed and it has been reported to reduce reactivation of 
VZV, expressing as zoster, by 50%. [41] Possible effects of this vaccine on VZV 
neurological manifestations has not been established. However, cases of VZV meningitis 
following vaccination in elderly have been reported. [42] 
HSV-1 and HSV-2 were responsible of 6 and 2 cases respectively. All patients with HSV-1 
infection had meningoencephalitis, all cases with HSV-2 infection had meningitis, including 
one case of Mollaret syndrome. Out of six cases of HSV-1 infection, two occurred in 
patients with known causes of immunosuppression, namely hypogammaglobulinemia in one 
case and steroids plus methotrexate for rheumatoid arthritis in the other case; additionally, 
two other patients were 84 and 85 years old. This is consistent with the existing literature 
indicating HSV-1 as a typical opportunistic infection. Differently, all three patients with 
HSV-2 infection had no history or findings suggestive of immunosupression. Two out of six 
patients with HSV-1 infection died while all the three patients with HSV-2 infection fully 
recovered. These data confirm HSV-1 and HSV-2 to cause different kinds of involvement 
of the CNS, with different clinical manifestations and outcome. Treatment of HSV-1 and 
HSV-2 traditionally relies on acyclovir, since its introduction more than 30 years ago. 
Resistant strains have been described, but susceptibility tests are not routinely performed, 
since they are not standardized, time-demanding and their clinical relevance not established. 
[43] Acyclovir has also been variously prescribed for primary or secondary prophylaxis, but 
emergence of resistance has been described. [44] 
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Toscana virus turned out to be the second cause of viral infection of the CNS in our case 
series, together with HSV-1. All cases occurred during summer season, consistently with 
the presence of the vector sand-fly. Four cases had meningitis and two cases 
meningoencephalitis. Another case of meningitis was probably linked to Toscana virus 
based on positive serological results. These data confirm Toscana virus to be an emerging 
infection in the Mediterranean area, including our area. Three out of six patients were not 
born in Italy. Although figures are too little to allow any conclusion, we can speculate that 
possibly Toscana virus is more likely to induce severe clinical manifestations in non-
immune adults and that it is probably quite spread in our communities. Many case reports in 
travelers and clinical research and epidemiologic studies conducted around the 
Mediterranean region have shown that Toscana virus has a tropism for the CNS and is a 
major cause of meningitis and encephalitis in countries in which it circulates. In central 
Italy, Toscana virus is the most frequent cause of meningitis from May to October, far 
exceeding enteroviruses. For instance, out of 120 cases of neuroinvasive infections, in 
Emilia Romagna in 2012, 28.3% of cases had Toscana virus antibodies and 79.4% of them 
were in the acute phase of the infection. [45] In other northern Mediterranean countries, 
TOSV is among the 3 most prevalent viruses associated with meningitis during the warm 
seasons. [46] Only in 1 out of four cases some kind of immunosuppression was present; in 
fact, differently by VZV and HSV-1, Toscana virus is not a typical opportunistic agent. In a 
series of 17 cases reported in France, All patients presented with fever and neurological 
signs were observed such as aseptic meningitis (n = 6), muscular symptoms (n = 3), or 
encephalitis (n = 4). The outcome was always favorable. At the acute stage, IgM were 
observed in 14/17 patients, neutralization tests were positive for 3/8 patients, and RT-PCR 
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confirmed Toscana virus infections in 5/8 CSF specimens. [47] Although Toscana virus 
infection is usually mild, severe encephalitis cases have been reported. [48] 
No treatment options are currently available. A study on prevention from infection by 
Toscana virus reported that a combination of recombinant Toscana virus structural proteins 
N-Gc, used as a vaccine, protected 100% of mice infected with a lethal, neurovirulent strain 
of Toscana virus. [49] Other than prevention and antiviral therapy, repellents and 
insecticides are the principal options to reduce the spread of sandfly-borne diseases. 
Spraying campaigns are usually focused on inhabited areas and thus efficient against 
anthoponotic sandflies, such as P. papatasi. The efficacy is much lower against non-
anthoponotic sandflies, such as those belonging to the Laroussius subgroup. However, 
without precise mapping of sandfly habitats and breeding areas, insecticide spraying is 
likely to be poorly effective. Because so little is known about natural breeding sites of 
sandflies, the preimaginal stages are rarely targeted by control measures. In campaigns 
against the adult sandflies, assessments of efficacy and cost/benefit are difficult to make 
because there are few properly controlled studies, and the results of different interventions 
are seldom compared. Insecticide spraying significantly decreases the incidence of 
Phlebotomus-transmitted diseases only if spraying is continuous; sporadic campaigns are 
considered to be ineffective. Several properties of the sandfly-borne phleboviruses make 
them good candidates for further emergence as human pathogens. Because the geographic 
distribution of these agents is dictated by the distribution of their vectors, climate change 
can modulate at-risk areas and human populations. The high rate of mutation of these 
viruses due to the lack of proofreading activity of the viral RNA polymerase generates 
quasispecies populations, a situation favoring the selection of variants with modified 
phenotypes, potentially including increased virulence and/or transmission efficiency. The 
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propensity for genetic reassortment or recombination under conditions of mixed infections 
may result in recombinant viruses with significantly altered pathogenicity characteristics, as 
has been observed with other genera in the Bunyaviridae family.  [50, 51] By definition all 
arboviruses have the capacity to infect and replicate in both vertebrates and invertebrates. 
Thus, arboviruses have evolved the capability of infecting widely different hosts that 
present very distinct biochemical challenges. This “plasticity” in their life cycles increases 
their capacity to cross species barriers, an essential requirement for virus emergence. [52] 
Enteroviruses were responsible for one case of meningitis, one of meningoencephalitis and 
one of myelitis. All patients were immunocompetent and all of them fully recovered, 
consistently with the existing literature. 
Two patients had West Nile virus IgM in the study period, consistently with the definition 
of probable case established by the European Centers for Disease Control. One patient had 
meningitis and one had myelitis. Both occurred in immunocompetent patients. Human cases 
of WNV-associated fever and/or neurological disorders have been reported in Italy since 
2008. The first outbreak occurred in the northeastern region of Italy surrounding the Po 
River and was caused by the Po River lineage 1 strain, and since then, WNV infections have 
been reported in several regions of central Italy. Although the virus is highly genetically 
conserved, stochastic mutations in its genome may lead to the emergence of new strains, as 
was observed in Italy in 2011 with the identification of two new lineage 1 strains, the WNV 
Piave and WNV Livenza strains. [53] Confirmed human cases have been reported in Puglia, 
Lombardia, Veneto, Emilia Romagna and Sardinia Italian regions. [54] West Nile virus 
transmission has been confirmed in the last four years in Europe and in the Mediterranean 
Basin. An increasing concern towards West Nile disease has been observed due to the high 
number of human and animal cases reported in these areas confirming the importance of 
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this zoonosis. A new epidemiological scenario is currently emerging: although new 
introductions of the virus from abroad are always possible, confirming the epidemiological 
role played by migratory birds, the infection endemisation in some European territories 
today is a reality supported by the constant reoccurrence of the same strains across years in 
the same geographical areas. Despite the WND reoccurrence in the Old World, the 
overwintering mechanisms are not well known, and the role of local resident birds or 
mosquitoes in this context is poorly understood. A recent new epidemiological scenario is 
the spread of lineage 2 strains across European and Mediterranean countries in regions 
where lineage 1 strain is still circulating creating favourable conditions for genetic 
reassortment and emergence of new strains. [55] 
In case symptoms of cerebral parenchyma involvement are present, VZV and HSV-1 were 
the most frequent etiology and should be considered in such a case; in case of pure 
meningitis, Toscana virus and HSV-2 were the most frequent etiology and should be 
considered in such a case. 
Plain CT scan is not able to detect signs of meningitis or encephalitis and it can only be 
useful in ruling out contraindications to lumbar puncture. We believe at least in cases signs 
of encephalitis are evident at presentation magnetic resonance should be considered as first 
line examination. 
EEG confirms its role in the diagnosis and follow-up of CNS infections. 
An increased WBC count, particularly neutrophils, was present at admission in a relevant 
number of cases, and no concomitant bacterial infection was detected, meaning that this 
cannot be used as a criterion to discriminate between bacterial and viral infection of the 
CSF. On the opposite, procalcitonin seems to confirm its correlation with bacterial etiology. 
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An increased WBC count in CSF, usually lymphocytes, was present in almost all cases, 
confirming this to be a criterion to confirm or rule out meningitis. CSF/blood glucose level, 
more than absolute CSF glucose level, is a highly sensitive parameter to distinguish 
between aseptic and bacterial meningitis, also in line with recent reports. [56] 
Mean WBC count was 285x109/L, Enterovirus infection was associated with a mean WBC 
of 152x109/L and VZV infection with a mean WBC of 625x109/L. The fact that Enterovirus 
induced a mild inflammatory reaction in terms of leukocytes, is consistent with what 
already reported. [34] What is quite noteworthy is the significantly stronger inflammatory 
response, both in terms of leukocytes and proteins, induced by VZV in comparison with 
other etiologies in our case series. 
The results of the seroprevalence survey confirm Toscana virus to be widely spread in our 
area. A wider seroprevalence survey conducted in the area of Siena found 19.8% of adults 
to be immunized against Toscana virus, with an age-dependent trend. [57] Other data 
indicate a seroprevalence of Toscana virus of 77.2% in the forestry workers of the Tuscany 
region. This fact is strictly correlated with the ecological niches specific for the survival of 
Toscana virus arthropod vector. [58]  
Climate changes might impact on vectors activity and spread of emerging infections such as 
West Nile and Toscana virus infection. 
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Conclusions 
 
VZV and TOSV are the most common causes of CNS viral infection in our setting. West 
Nile is an emerging cause of infection also in our area. VZV and HSV-1 are more 
frequently associated with brain parenchyma involvement. 
An early lumbar puncture is necessary to increase the probability of obtaining an etiologic 
diagnosis. A high WBC count with a lymphocyte predominance, high or normal glucose 
levels and high proteins in CSF examination are suggestive of viral meningitis. Higher 
levels of WBC and proteins in CSF are suggestive of VZV infection while milder 
inflammatory response is suggestive of Enterovirus infection. 
Procalcitonin levels may be useful in distinguishing between viral and bacterial meningitis 
while WBC count is not a sensible predictor. 
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